Lipocine Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lipocine Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q2 2024.
  • Lipocine Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $224K, a 44.9% decline year-over-year.
  • Lipocine Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.22M.
  • Lipocine Inc. annual Nonoperating Income (Expense) for 2023 was $1.58M, a 16% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.22M $224K -$183K -44.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.4M $291K -$177K -37.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.58M $312K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $392K -$97.8K -20% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $407K -$489K -54.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $469K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $490K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $896K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q3 2018 -$106K -$172K -261% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$91.1K -$142K -279% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$82.3K -$131K -270% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-07
Q3 2017 $65.8K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $50.9K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $48.4K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.